<i id='6CAC715507'><strike id='6CAC715507'><tt id='6CAC715507'><pre id='6CAC715507'></pre></tt></strike></i> 
WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.
In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.
advertisement
“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED Log In
Peter Hotez and the public health issue of online harassment 
ASCO Daily Recap: Safety data from Novartis, survival from Pfizer 
Apple is now the first public company to be valued at $3 trillion 
At ASCO, pharma leaders speak of advances in 'smart bomb' drugs 
Cancer drug shortages should be causing more outrage 
Innovation in antibiotics is ailing. 'Brain drain' may kill it 
Medical leaders decry Supreme Court decision on affirmative action 
HIV drugs protect against transmission, even in unprotected sex 
Medicare proposal to cover medical devices draws a mixed reaction 
ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers 
ChatGPT in medicine: STAT answers readers' burning questions 
Reframing the conversation around gain 
As demand for Covid shots wanes, Moderna seeks its next success 
Woman returns to dialysis after doctors remove transplanted pig kidney 
Hollywood unions extend contract negotiations for actors 
